Selling LEAP Puts: Institutional Mechanics & Retail Traps — Wiki | SOPHIE

Overview

Selling a LEAP put (1+ year to expiration) is not a theta-decay income strategy the way a 30-day put is — it's dominated by Delta and Vega, not time decay. The two legitimate institutional uses are strategic acquisition (a synthetic limit order, “Buffett-style”) and volatility arbitrage (a short-Vega bet on IV mean reversion). Retail traders who sell LEAPs for “income” are using capital inefficiently and walking into illiquidity, Vega, and dead-money traps institutions are structured to avoid.

Key Concepts

Greek Profile: LEAP vs. 30-Day — a 2-year ATM put has extremely high Vega ( ~~$2.50) vs. a 30-day put's low Vega (~$ 0.40); LEAP Theta is low/linear (~~ $0.40/day) vs. 30-day's high/exponential (~$ 9.00/day); LEAP Gamma is stable/low (0.001) vs. 30-day's explosive/high (0.008) gamma risk.
Strategy A: Acquisition — OTM strikes (delta -0.20 to -0.40), goal is assignment at a discount ("Buffett-style" synthetic limit order); risk is missing upside if the stock rallies instead.
Strategy B: Volatility Arbitrage — ATM strikes (delta ~-0.50), goal is maximizing Vega exposure to profit from IV mean reversion; risk is the "Vega time bomb" if IV expands instead of contracting.
Deep ITM Financing — delta -0.80 to -1.0, functions as synthetic stock ownership with capital efficiency benefits, but carries early-assignment risk around dividends.

Institutional Case Studies

The Buffett Put (Coca-Cola, 1993) — Buffett sold 5M puts at a $35 strike (KO traded at$ 40, and he wanted to own it at $35), collecting$ 7.5M in premium. The stock stayed above $35, puts expired worthless — he was paid to make a purchase decision he wanted to make anyway.
The OXY Misconception (2019) — often mischaracterized as a put sale; Berkshire's $10B into Occidental Petroleum was actually Strategic Financing (8% preferred stock + warrants), a long volatility play via the warrants, not a short-put strategy.
Dividend Arbitrage Counterparty — deep ITM LEAP puts are often bought by dividend arbitrageurs running a conversion/box-spread: buy stock + deep ITM put, collect the dividend, then exercise the put to sell at the fixed strike. The LEAP seller supplies the liquidity for this near risk-free institutional trade.

Quantitative Pitfalls (The Retail Traps)

Illiquidity & Slippage — LEAP bid-ask spreads are dramatically wider than monthly options (e.g. ~2% one-way slippage on SPY LEAPs, 13%+ on a volatile single name), making a round-trip "roll" prohibitively expensive.
The Vega Time Bomb — a flat stock price can still produce a large loss purely from IV expansion: modeling a short 2-year ATM put at 54% initial IV, an IV spike to 70% loses money even with zero price movement, while an IV crush to 35% is the profitable outcome — the position's P/L is driven by fear, not direction.
Capital Inefficiency ("Dead Money") — a 2-year LEAP put's max return on capital (~18%) is dramatically lower than a compounded series of monthly puts over the same period (~131%), since capital is locked and can't be redeployed.

The "No-Exit" Rule

Because of the illiquidity trap, a LEAP put seller should assume they're committed to the position for the full term. There are three outcomes: Assignment (take delivery of shares — optimal for acquirers), Expiration (option expires worthless, keep 100% premium — optimal for vol arb), or Emergency Close (only justified if profit exceeds ~50% early, since the spread cost of exiting is otherwise prohibitive).

Key Takeaways